Archive: home delivery
Last Chance to Invest in Disrupting CVS and Walgreens
By Andy Gordon on June 15, 2020
Time is running out to invest in NowRx. When we urged you to invest last November, it was a compelling opportunity. Since then, it’s gone from compelling to irresistible. Growth has taken off. And Friday is your last chance to invest in this very impressive healthcare startup. Here’s what I said when I recommended NowRx to you last November… With…
Invest In A Wine Startup With A Massive Inventory
By Andy Gordon on May 28, 2020
Deal Details Startup: Yahyn Security type: Common equity Round size: Up to $20 million Valuation: $4,955,781 Share price: $44.38 Minimum investment: $133.14 Raise: Seed Investment Portal: Netcapital Deadline: June 30, 2020 COVID-19 is changing our world in so many ways. Socially. Professionally.
Winc Sees ‘Massive Opportunity’ Moving Forward
By Andy Gordon on May 21, 2020
Much has changed since we recommended Winc last December. The popular direct-to-consumer wine company was one of the last pre-pandemic recommendations we made. Now lockdowns and quarantines have become our normal. And with so many of us stuck at home, meals have taken center stage in our lives. So it’s…
NowRx Facing “Unprecedented” Demand
By Andy Gordon on May 18, 2020
When we first recommended NowRx to you in July 2018, its valuation was $20 million. Last November, we recommended you invest in the company again at a $65 million valuation — a more than 3X increase on your original investment price. We were impressed by its execution and…